Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Fasting Hypoglycemia

pyridostigmine bromide has been researched along with Fasting Hypoglycemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carballo, A; Casanueva, FF; Dieguez, C; Peñalva, A; Pombo, M1
Barkan, AL; DeMott-Friberg, R; Jaffe, CA1
Aimaretti, G; Bartolotta, E; Bellone, J; Bellone, S; Camanni, F; Cappa, M; Dammacco, F; Ghigo, E; Loche, S1
Falhof, J; Hoeck, HC; Jakobsen, PE; Laurberg, P; Vestergaard, P1
Frohman, LA; Kelijman, M1
Casanueva, FF; Cordido, F; Dieguez, C1

Trials

1 trial(s) available for pyridostigmine bromide and Fasting Hypoglycemia

ArticleYear
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    The Journal of clinical investigation, 1996, Feb-15, Volume: 97, Issue:4

    Topics: Adrenergic alpha-Agonists; Arginine; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Hypoglycemia; Levodopa; Male; Pyridostigmine Bromide; Secretory Rate; Somatostatin

1996

Other Studies

5 other study(ies) available for pyridostigmine bromide and Fasting Hypoglycemia

ArticleYear
Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:1

    Topics: Adult; Atropine; Growth Hormone; Growth Hormone-Releasing Hormone; Hormones; Humans; Hypoglycemia; Insulin; Kinetics; Male; Oligopeptides; Pyridostigmine Bromide; Reference Values; Time Factors

1993
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:9

    Topics: Adolescent; Arginine; Child; Child, Preschool; Clonidine; Exercise; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Pyridostigmine Bromide; Reproducibility of Results

1996
Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:4

    Topics: Adult; Clonidine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemia; Hypothalamic Diseases; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Diseases; Pyridostigmine Bromide; Reproducibility of Results

2000
The role of the cholinergic pathway in growth hormone feedback.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Arginine; Cholinergic Fibers; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Male; Pituitary Gland; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone

1991
Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:5

    Topics: Adolescent; Adult; Arginine; Child; Cholinergic Fibers; Clonidine; Drug Interactions; Female; Growth Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Middle Aged; Obesity; Prolactin; Pyridostigmine Bromide; Synaptic Transmission; Thyrotropin; Thyrotropin-Releasing Hormone

1990